Genistein prevents myocardial hypertrophy in 2-kidney 1-clip renal hypertensive rats by restoring eNOS pathway

Pharmacology

Volumn 86, Issue 4, 2010, Pages 240-248

  Li, Jie ^a,b   Xie, Zhi Zhong ^a,c   Tang, Yong Bo ^a,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Endothelial nitric oxide synthase; Genistein; Hypertension; Left ventricular hypertrophy; Nitric oxide

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CALMODULIN; CAVEOLIN 3; COLLAGEN TYPE 1; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENISTEIN; HEAT SHOCK PROTEIN 90; NITRIC OXIDE;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME BINDING; HEART; HEART LEFT VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION;

ANGIOTENSIN II; ANIMALS; COLLAGEN TYPE I; CYCLIC GMP; GENE EXPRESSION REGULATION; GENISTEIN; HYPERTENSION, RENOVASCULAR; HYPERTROPHY, LEFT VENTRICULAR; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 2; VENTRICULAR REMODELING;

EID: 77957733987     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320457     Document Type: Article

References (31)

1. Reudelhuber TL, Bernstein KE, Delafontaine P: Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look. Hypertension 2007; 49: 1196-1201. (Pubitemid 46809352)
2. De Simone G, Pasanisi F, Contaldo F: Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension 2001; 38: 13-18. (Pubitemid 34224764)
3. Paulis L, Simko F: La419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodeling. Hypertension 2007; 50: 1009-1011. (Pubitemid 350172920)
4. Wenzel S, Rohde C, Wingerning S, Roth J, Kojda G, Schluter KD: Lack of endothelial nitric oxide synthase-rived nitric oxide formation favors hypertrophy in adult ventricular cardiomyocytes. Hypertension 2007; 49: 193-200. (Pubitemid 46360360)
5. Flaherty MP, Brown M, Grupp IL, Schultz JE, Murphree SS, Jones WK: eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression. Cardiovasc Toxicol 2007; 7: 165-177. (Pubitemid 47575002)
6. Kobayashi N, Mori Y, Nakano S, Tsubokou Y, Kobayashi T, Shirataki H, Matsuoka H: TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats. Atherosclerosis 2001; 158: 359-368. (Pubitemid 32913645)
7. Ruiz-Hurtado G, Fernandez-Velasco M, Mourelle M, Delgado C: La419, a novel nitric oxide donor, prevents pathological cardiac remodeling in pressure-overloaded rats via endothelial nitric oxide synthase pathway regulation. Hypertension 2007; 50: 1049-1056. (Pubitemid 350172926)
8. Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer- Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD: Cardiomyocyte- specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 2004; 94: 1256-1262. (Pubitemid 38656413)
9. Tang YB, Wang QL, Zhu BY, Huang HL, Liao DF: Phytoestrogen genistein supplementation increases eNOS and decreases caveolin- 1 expression in ovariectomized rat hearts. Sheng Li Xue Bao 2005; 57: 373-378.
10. Wang X, Abdel-Rahman AA: Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts. Am J Physiol Heart Circ Physiol 2002; 282:H2309-H2315.
11. Vera R, Sanchez M, Galisteo M, Villar IC, Jimenez R, Zarzuelo A, Perez-Vizcaino F, Duarte J: Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity. Clin Sci (Lond) 2007; 112: 183-191. (Pubitemid 46253885)
12. 2+ -independent activation of endothelial nitric-oxide synthase/HSP90 involving ERK1/2 and AKT phosphorylation in human endothelial cells. J Biol Chem 2006; 281: 27335-27345. (Pubitemid 44401761)
13. Liu D, Homan LL, Dillon JS: Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 5' -monophosphate-dependent mechanism. Endocrinology 2004; 145: 5532-5539. (Pubitemid 39564593)
14. Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y: Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension. Respiration 2006; 73: 105-112. (Pubitemid 43296247)
15. Shi XL, Wang GL, Zhang Z, Liu YJ, Chen JH, Zhou JG, Qiu QY, Guan YY: Alteration of volume-regulated chloride movement in rat cerebrovascular smooth muscle cells during hypertension. Hypertension 2007; 49: 1371-1377. (Pubitemid 46809382)
16. Zeng J, Zhang Y, Mo J, Su Z, Huang R: Twokidney, two-clip renovascular hypertensive rats can be used as stroke-prone rats. Stroke 1998; 29: 1708-1713, discussion 1713-11704 (Pubitemid 28365596)
17. Zhou JG, Ren JL, Qiu QY, He H, Guan YY: Regulation of intracellular Cl - concentration through volume-regulated CIC-3 chloride channels in A10 vascular smooth muscle cells. J Biol Chem 2005; 280: 7301-7308. (Pubitemid 40341288)
18. 2+ in human atrial myocardium. Am J Physiol Cell Physiol 2006; 290:C1437-C1445.
19. Hiyoshi H, Yayama K, Takano M, Okamoto H: Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension. Hypertension 2005; 45: 967-973. (Pubitemid 40628945)
20. Wang P, Tang F, Li R, Zhang H, Chen S, Liu P, Huang H: Contribution of different Nox homologues to cardiac remodeling in twokidney two-clip renovascular hypertensive rats: effect of valsartan. Pharmacol Res 2007; 55: 408-417. (Pubitemid 46560393)
21. Voros S, Yang Z, Bove CM, Gilson WD, Epstein FH, French BA, Berr SS, Bishop SP, Conaway MR, Matsubara H, Carey RM, Kramer CM: Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling. Am J Physiol Heart Circ Physiol 2006; 290:H1004-H1010.
22. Matsubara H: Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998; 83: 1182-1191. (Pubitemid 29006033)
23. Brede M, Roell W, Ritter O, Wiesmann F, Jahns R, Haase A, Fleischmann BK, Hein L: Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice. Hypertension 2003; 42: 1177-1182. (Pubitemid 37549074)
24. Ritter O, Schuh K, Brede M, Rothlein N, Burkard N, Hein L, Neyses L: AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway. Faseb J 2003; 17: 283-285.
25. Balligand JL: Heat shock protein 90 in endothelial nitric oxide synthase signaling: following the lead(er)? Circ Res 2002; 90: 838-841.
26. Murata T, Sato K, Hori M, Ozaki H, Karaki H: Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. J Biol Chem 2002; 277: 44085-44092. (Pubitemid 36157836)
27. Jagnandan D, Sessa WC, Fulton D: Intracellular location regulates calcium-calmodulin- dependent activation of organelle-restricted eNOS. Am J Physiol Cell Physiol 2005; 289:C1024-C1033. (Pubitemid 41430168)
28. Shaul PW: Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 2002; 64: 749-774. (Pubitemid 34259248)
29. Wang D, Gutkowska J, Marcinkiewicz M, Rachelska G, Jankowski M: Genistein supplementation stimulates the oxytocin system in the aorta of ovariectomized rats. Cardiovasc Res 2003; 57: 186-194. (Pubitemid 36009450)
30. Ou J, Fontana JT, Ou Z, Jones DW, Ackerman AW, Oldham KT, Yu J, Sessa WC, Pritchard KA Jr: Heat shock protein 90 and tyrosine kinase regulate eNOS NO .* generation but not NO .* bioactivity. Am J Physiol Heart Circ Physiol 2004; 286:H561-H569. (Pubitemid 38140336)
31. Si H, Liu D: Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats. J Nutr 2008; 138: 297-304. (Pubitemid 351213643)